Totally endoscopic mitral valve replacement: reasons for non-feasibility of repair and 5-year outcomes
Despite a higher comorbidity burden and residual baseline imbalance after matching, early and mid-term outcomes were acceptable and totally endoscopic chordal-sparing MV replacement represents a safe and clinically effective treatment option for selected patients.